Pascual Sonia, Such José, Esteban Angel, Zapater Pedro, Casellas Juan A, Aparicio José R, Girona Eva, Gutiérrez Ana, Carnices Fernando, Palazón Jose M, Sola-Vera Javier, Pérez-Mateo Miguel
Liver Unit, Department of Internal Medicine, University General Hospital of Alicante C/Pintor Baeza s/n, Alicante 03010, Spain.
Hepatogastroenterology. 2003 Sep-Oct;50(53):1482-6.
BACKGROUND/AIMS: The dysfunction of the intestinal barrier is a factor that has been related to bacterial translocation from lumen to extra-intestinal sites and consequently to the development of spontaneous bacterial peritonitis. The aim of this study was to investigate if the alterations of the intestinal barrier in cirrhosis are related with the degree of liver failure and associated with other clinical complications.
Intestinal permeability was assessed by means of the lactulose/mannitol test in 79 cirrhotic and 25 controls subjects. They received 10 g of lactulose and 5 g of mannitol. Lactulose and mannitol were measured in a five-hour urinary volume.
Lactulose/mannitol ratio was significantly higher in cirrhotic patients than in controls (p = 0.03). This was more evident in end-stage cirrhosis. Patients with ascites, or encephalopathy showed a statistically significant increase in lactulose/mannitol ratio when compared to patients without these complications.
The increased intestinal permeability is related to the progression of the liver disease and is more relevant with overt clinical complications. This is due to an increased absorption of lactulose. However, as liver disease progresses, mannitol absorption is progressively reduced, probably due to a reduced surface of absorption, and these events are more relevant in patients with overt clinical complications.
背景/目的:肠道屏障功能障碍是一个与细菌从肠腔向肠外部位移位相关的因素,进而与自发性细菌性腹膜炎的发生有关。本研究的目的是调查肝硬化患者肠道屏障的改变是否与肝衰竭程度相关,并与其他临床并发症有关。
通过乳果糖/甘露醇试验评估79例肝硬化患者和25例对照者的肠道通透性。他们服用10克乳果糖和5克甘露醇。在5小时尿量中测量乳果糖和甘露醇。
肝硬化患者的乳果糖/甘露醇比值显著高于对照组(p = 0.03)。这在终末期肝硬化中更为明显。与没有这些并发症的患者相比,有腹水或肝性脑病的患者乳果糖/甘露醇比值有统计学意义的升高。
肠道通透性增加与肝脏疾病的进展有关,并且与明显的临床并发症更为相关。这是由于乳果糖吸收增加所致。然而,随着肝脏疾病的进展,甘露醇吸收逐渐减少,可能是由于吸收表面积减少,这些情况在有明显临床并发症的患者中更为明显。